Karol Elizabeth Watson MD

Adult Congenital Heart Disease

Co-director, UCLA Program in Preventive Cardiology

Summary

Dr. Karol Watson, based in Los Angeles, CA, is a cardiologist with subspecialty expertise in Preventive Cardiology. She completed her education at Harvard Medical School and further trained at UCLA David Geffen School of Medicine/UCLA Medical Center, where she also completed her residency and fellowship in Cardiovascular Disease. She is a specialist in hypertension and lipid metabolism disorders. She has been a member of national lipid and hypertension guidelines writing committees. Dr. Watson has contributed to various publications on topics including racial disparities in diabetes and the biochemical response to Vitamin D3. She is a principal investigator in several clinical trials such as the Multi-Ethnic Study of Atherosclerosis (MESA). Her professional achievements include receiving CMS Meaningful Use Stage 1 Certification, recognition as a Super Doctor, and being named in Who's Who in Medicine and Healthcare, as well as being a Fellow of the American College of Cardiology, Fellow of the American Heart Association, Fellow of the American Society of Preventive Cardiology, and Fellow of the American Board of Clinical Lipidology

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1992 - 1998
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1992
Harvard Medical SchoolClass of 1989

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Fellow (FACC) American College of Cardiology
Join now to see all

Multi-Ethnic Study of Atherosclerosis (MESA) Start of enrollment: 1999 Jan 01
Active, not recruiting
Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Daily Blood Glucose Trends in Patients at Risk for Diabetes Start of enrollment: 2023 Oct 01
Not yet recruiting
Not Applicable
Roles: Contact, Principal Investigator, Sponsor-Investigator

PubMed

Journal Articles

Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older Adults
Alain Bertoni, Gerard Criner, Mark T Dransfield, Meilan K Han, Nadia N Hansel, Erin D Michos, Elizabeth C Oelsner, Karol E Watson, JAMA
A Reference Set of Curated Biomedical Data and Metadata from Clinical Case Reports
Shaun P Setty, Karol E Watson, Nature
Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study
Edward J Boyko, Karol E Watson, Ana C Ricardo, The Journal of Clinical Endocrinology and Metabolism
The Present and Future JACC State-of-the-Art Review Coronary Calcium Score and Cardiovascular Risk
Michael J Blaha, Matthew J Budoff, Philip Greenland, Karol E Watson, ScienceDirect
Join now to see all

Lectures

PCSK-9 Inhibitors Appropriate Use and Benefits Application in Minority Populations
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
New Paradigms in Contemporary Cardiovascular Care: Application of Guideline-Directed Therapies Im plications for Minority Populations and Resolution of Dispariti...
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Interleukin-10 as a Predictor of Major Adverse Cardiovascular Events in a Racially and Ethnically Diverse Population: Multi-Ethnic Study of Atherosclerosis
Contemporary Forums, Jackson Hole, Wyoming - 7/29/2012

Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older AdultsJune 2020
For Stable Chest Pain, CCTA Evaluation Lowers Longer-Term RiskAugust 2018

What You Need to Know About Blood ThinnersNovember 15th, 2024
Prevalence and Outcomes of Persistent Hypertension Postpartum in Women with a Hypertensive Disorder of PregnancyAugust 19th, 2024
Promising First Results with DNA Editing to Lower LDLNovember 20th, 2023
Join now to see all

Building BRIDGEs: Coordinating Standards, Diversity, and Ethics to Advance Biomedical AIUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2026
Building BRIDGEs: Coordinating Standards, Diversity, and Ethics to Advance Biomedical AIUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2026
Cardiovascular Scientist Training ProgramUNIVERSITY OF CALIFORNIA LOS ANGELES1998–2025